JP2021529736A5 - - Google Patents
Info
- Publication number
- JP2021529736A5 JP2021529736A5 JP2020570685A JP2020570685A JP2021529736A5 JP 2021529736 A5 JP2021529736 A5 JP 2021529736A5 JP 2020570685 A JP2020570685 A JP 2020570685A JP 2020570685 A JP2020570685 A JP 2020570685A JP 2021529736 A5 JP2021529736 A5 JP 2021529736A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- amino acid
- composition
- acid entity
- nac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687724P | 2018-06-20 | 2018-06-20 | |
| US62/687,724 | 2018-06-20 | ||
| US201862758249P | 2018-11-09 | 2018-11-09 | |
| US62/758,249 | 2018-11-09 | ||
| US201962794165P | 2019-01-18 | 2019-01-18 | |
| US62/794,165 | 2019-01-18 | ||
| PCT/US2019/038055 WO2019246310A1 (en) | 2018-06-20 | 2019-06-19 | Compositions and methods for the reduction or treatment of inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021529736A JP2021529736A (ja) | 2021-11-04 |
| JP2021529736A5 true JP2021529736A5 (https=) | 2022-09-02 |
Family
ID=67253998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020570685A Pending JP2021529736A (ja) | 2018-06-20 | 2019-06-19 | 炎症の軽減又は治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210260010A1 (https=) |
| EP (1) | EP3810276A1 (https=) |
| JP (1) | JP2021529736A (https=) |
| CN (1) | CN112839712A (https=) |
| MA (1) | MA52961A (https=) |
| WO (1) | WO2019246310A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| JP2021529735A (ja) | 2018-06-20 | 2021-11-04 | アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． | アミノ酸組成物の製造方法 |
| US20210379118A1 (en) * | 2018-10-19 | 2021-12-09 | Regenics As | Use of egg cellular extract for wound healing |
| WO2023009444A1 (en) * | 2021-07-26 | 2023-02-02 | Axcella Health Inc. | Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19 |
| US11622949B1 (en) | 2022-08-04 | 2023-04-11 | Gad M. Gilad | Agmatine compositions for treatment of osteoarthritis |
| US12285541B2 (en) | 2023-01-26 | 2025-04-29 | Insignia Pharmaceuticals, Llc | Pharmaceutical compositions for treating osteoarthritis |
| CN116549428B (zh) * | 2023-06-20 | 2025-05-16 | 郑州大学 | 4-羟基异亮氨酸的新用途 |
| WO2025155743A1 (en) * | 2024-01-16 | 2025-07-24 | The Johns Hopkins University | Chemokine ligand 18 (ccl18) for diagnosis and treatment of inflammatory lung disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2007004613A1 (ja) * | 2005-07-01 | 2009-01-29 | 味の素株式会社 | 炎症性腸疾患治療薬及びＴＮＦ−α産生抑制剤 |
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| CN100518815C (zh) * | 2007-02-15 | 2009-07-29 | 北京苏里曼医药科技有限公司 | 一种氨基酸组合物 |
| CA2863809A1 (en) * | 2012-02-06 | 2013-08-15 | Ajinomoto Co., Inc. | Prophylactic or therapeutic agent for idiopathic inflammatory myopathies |
| KR102324674B1 (ko) * | 2015-11-02 | 2021-11-11 | (주)모아캠 | 아미노산 및 해양 심층수 추출 미네랄을 유효성분으로 함유하는 화장료 조성물 |
| JOP20190147A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات |
-
2019
- 2019-06-19 EP EP19739469.5A patent/EP3810276A1/en not_active Withdrawn
- 2019-06-19 US US17/254,131 patent/US20210260010A1/en not_active Abandoned
- 2019-06-19 WO PCT/US2019/038055 patent/WO2019246310A1/en not_active Ceased
- 2019-06-19 CN CN201980054580.3A patent/CN112839712A/zh active Pending
- 2019-06-19 MA MA052961A patent/MA52961A/fr unknown
- 2019-06-19 JP JP2020570685A patent/JP2021529736A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021529736A5 (https=) | ||
| JP2020530845A5 (https=) | ||
| JP2018012722A5 (https=) | ||
| IL296055A (en) | Amino acid compositions for the treatment of liver disease | |
| JP2020502183A5 (https=) | ||
| JP2020504108A5 (https=) | ||
| US5866537A (en) | Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids | |
| US20080275120A1 (en) | Leucine rich composition | |
| JP2021527671A5 (https=) | ||
| JP2020517703A5 (https=) | ||
| EP3021690B1 (en) | Muscle preservation in overweight or obese adult during weight loss program | |
| JP2021527670A5 (https=) | ||
| JP2024520526A5 (https=) | ||
| CN103269697A (zh) | 半胱氨酸和食物摄入 | |
| JP2021527669A5 (https=) | ||
| CA2134380C (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man | |
| JP2008247896A (ja) | 透析患者用経口アミノ酸組成物 | |
| JP2008247896A6 (ja) | 透析患者用経口アミノ酸組成物 | |
| CN115427417A (zh) | 含有三磷酸腺苷（atp）的组合物和使用方法 | |
| JPH04159219A (ja) | 腎不全用経口アミノ酸製剤 | |
| JP2005206528A (ja) | アンジオテンシン変換酵素阻害剤及び該阻害剤を含む食品 | |
| JP2009515953A5 (https=) | ||
| WO2021133948A1 (en) | Compositions and methods for the treatment of liver diseases and disorders | |
| JP2006510640A (ja) | 胃腸に投与することができる配合物、およびその使用 | |
| Cynober et al. | 4. Metabolism and applications of functional amino acids in human nutrition |